Medical organogel processes and compositions
US-9205150-B2 · Dec 8, 2015 · US
US12109307B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-12109307-B2 |
| Application number | US-201917261411-A |
| Country | US |
| Kind code | B2 |
| Filing date | Jul 19, 2019 |
| Priority date | Jul 20, 2018 |
| Publication date | Oct 8, 2024 |
| Grant date | Oct 8, 2024 |
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
What the patent document calls the invention.
A short plain-language summary of the technical disclosure.
Who owns or filed the patent and who is credited as inventor.
Filing, priority, publication, and grant dates set the timeline.
The legal scope of protection — read this for what is actually claimed.
Technology tags used to group this patent with similar filings.
Prior art links and similar publications in this corpus.
Official abstract text for this publication.
The present disclosure provides compositions and methods for controlled release of macromolecules (such as proteins and polypeptides). The present disclosure also provides method for preparing and using the same.
Opening claim text (preview).
What is claimed is: 1. A composition comprising one or more hydrogel forming polymers, said hydrogel enables sustained release of a target agent, at least one of said one or more hydrogel forming polymers comprises a degradable backbone, and wherein said degradable backbone comprises precursor polymers linked by a degradable linker, wherein said hydrogel forming polymer is selected from the group consisting of a polysaccharide, a polyethylene glycol, a derivative thereof, and any combinations thereof; comprising at least a first hydrogel forming polymer derivative and a second hydrogel forming polymer derivative, wherein said first hydrogel forming polymer derivative comprises a first modification and said second hydrogel forming polymer derivative comprises a second modification, said first modification is different from said second modification, and said first polymer derivative is capable of reacting with said second polymer derivative to form said hydrogel; wherein a mass ratio between said first hydrogel forming polymer derivative and said second hydrogel forming polymer derivative in said composition is from about 3:1 to about 1:3; or wherein a molar ratio between said first hydrogel forming polymer derivative and said second hydrogel forming polymer derivative in said composition is from about 10:1 to about 1:10; or wherein a volume ratio between said first hydrogel forming polymer derivative and said second hydrogel forming polymer derivative in said composition is from about 3:1 to about 1:3; or wherein said first hydrogel forming polymer derivative has a first DM, said second hydrogel forming polymer derivative has a second DM, and a ratio between said first DM and said second DM is from about 3:1 to about 1:3. 2. The composition according to claim 1 , wherein said hydrogel forming polymer comprising the degradable backbone is formed by cross linking said precursor polymers with said degradable linker, wherein said degradable linker enables formation of degradable linkage between said precursor polymers and wherein said degradable linker comprises two or more modifications, and a degree of modification of said degradable linker is less than about 30%; wherein said modification of said degradable linker is selected from the group consisting of an acrylate, a methacrylate, a maleimide, a vinylsulfone, a thiol, an amine, and any combinations thereof. 3. The composition according to claim 1 , wherein said degradable linker is selected from the following groups: 4. A hydrogel for sustained release of a target agent, wherein said hydrogel is formed with the composition according to claim 1 . 5. The hydrogel according to claim 4 , wherein about less than 30% of said target agent is cumulatively released within an initial 24 hours from said hydrogel, and the remaining portion of said target agent is cumulatively released from said hydrogel in about 3 to about 36 months. 6. A method for producing a composition according to claim 1 , comprising: a) crosslinking the precursor polymer with the degradable linker to obtain the hydrogel forming polymer comprising the degradable backbone; and b) mixing said hydrogel forming polymer comprising the degradable backbone with an additional polymer, wherein said additional polymer is capable of reacting with said hydrogel forming polymer comprising the degradable backbone under a condition enabling formation of the hydrogel.
Polysaccharides; Derivatives thereof, e.g. gums, starch, alginate, dextrin, hyaluronic acid, chitosan, inulin, agar or pectin · CPC title
containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids · CPC title
Injectable compositions; Intramuscular, intravenous, arterial, subcutaneous administration; Compositions to be administered through the skin in an invasive manner (non-active ingredients are additionally classified in A61K47/00) · CPC title
Ointments; Bases therefor; {Other semi-solid forms, e.g. creams, sticks, gels (composition of ointments, creams or gels A61K47/00)} · CPC title
Dextran; Derivatives thereof · CPC title
Related publications grouped by family.
Answers are generated from the same data shown on this page.